The Readout: Speaking of Drug Prices
From the post:
How? Washington University law professor Rachel Sachs and Department of Veterans Affairs economist Austin Frakt suggest tying drug prices to cost-effectiveness. They'd also like society to pay more for preventive treatments and cures and less for lifelong treatments for chronic disease, in a bid to goad the industry to focus on developing treatments with more public benefit.
Read the full post here
Read the full post
Tags
fda health law policy pharmaceuticals public health regulation